Health & Medicine
Managing ‘internal clocks’ of post-harvest vegetables for health
24 Jun 2013
Vegetables and fruits don’t die the moment they are harvested; they respond to their environment for days, light can be used to coax them to make more cancer-fighting antioxidants at certain times of day
Targeted drug delivery could be transformed by microbubble technology
By By Michael Jones | 24 Jun 2013
Yale study reveals smoking is undertreated compared to other chronic conditions
By By Stacey Buba | 22 Jun 2013
WHO warns of new deadly SARS-like virus
20 Jun 2013
The virus is not unknown but the virulent strain is known to be resistant to most drugs available.
For some, it matters who's donating an organ, blood
By By Jared Wadley | 20 Jun 2013
Seeing the human pulse
20 Jun 2013
Yale research projects exploring new uses for failed drugs get NIH funding
By By Bill Hathaway | 19 Jun 2013
Fast-acting virus targets melanoma in mice
By By Bill Hathaway | 17 Jun 2013
Children help reveal diabetes trigger
14 Jun 2013
Yale researchers unravel genetics of dyslexia and language impairment
By By Karen N. Peart | 14 Jun 2013
New research links body clocks to osteoarthritis
13 Jun 2013
Brain’s ‘dark side’ linked to cocaine addiction
13 Jun 2013
Researchers find diabetes drug increases efficacy of anti-cancer therapies in melanoma treatment
12 Jun 2013
Researchers reveal malaria's deadly grip
12 Jun 2013
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
